Skip to content

International Union of Quaternary Research (INQUA), INQUA – Commission on Stratigraphy and Chronology (SACCOM)

Scientific Abstracts, qPCR, PCR, RT-PCR, cDNA, RNA

Menu
  • Home
  • Isotype
  • peptide
  • Lenti
  • elisa kits
  • antibody
  • Distributors
  • vector
  • cDNA
  • Contact Us
Menu
inqua-saccom

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Posted on April 29, 2021 by Leah

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

A recent report that 93 per cent of invasive cervical cancers worldwide contain human papillomavirus (HPV) may be an underestimate, due to sample inadequacy or integration events affecting the HPV L1 gene, which is the target of the polymerase chain reaction (PCR)-based test which was used. The formerly HPV-negative cases from this study have therefore been reanalyzed for HPV serum antibodies and HPV DNA. Serology for HPV 16 VLPs, E6, and E7 antibodies was performed on 49 of the 66 cases which were HPV-negative and a sample of 48 of the 866 cases which were HPV-positive in the original study.
Moreover, 55 of the 66 formerly HPV-negative biopsies were also reanalyzed by a sandwich procedure in which the outer sections in a series of sections are used for histological review, while the inner sections are assayed by three different HPV PCR assays targeting different open reading frames (ORFs). No significant difference was found in serology for HPV 16 proteins between the cases that were originally HPV PCR-negative and -positive. Type-specific E7 PCR for 14 high-risk HPV types detected HPV DNA in 38 (69 per cent) of the 55 originally HPV-negative and amplifiable specimens. The HPV types detected were 16, 18, 31, 33, 39, 45, 52, and 58. Two (4 per cent) additional cases were only HPV DNA-positive by E1 and/or L1 consensus PCR. Histological analysis of the 55 specimens revealed that 21 were qualitatively inadequate. Only two of the 34 adequate samples were HPV-negative on all PCR tests, as against 13 of the 21 that were inadequate ( p< 0.001).
inqua-saccom
inqua-saccom
Combining the data from this and the previous study and excluding inadequate specimens, the worldwide HPV prevalence in cervical carcinomas is 99.7 per cent. The presence of HPV in virtually all cervical cancers implies the highest worldwide attributable fraction so far reported for a specific cause of any major human cancer. The extreme rarity of HPV-negative cancers reinforces the rationale for HPV testing in addition to, or even instead of, cervical cytology in routine cervical screening.

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.

In December, 2019, a pneumonia associated with the 2019 novel coronavirus (2019-nCoV) emerged in Wuhan, China. We aimed to further clarify the epidemiological and clinical characteristics of 2019-nCoV pneumonia.In this retrospective, single-centre study, we included all confirmed cases of 2019-nCoV in Wuhan Jinyintan Hospital from Jan 1 to Jan 20, 2020. Cases were confirmed by real-time RT-PCR and were analysed for epidemiological, demographic, clinical, and radiological features and laboratory data. Outcomes were followed up until Jan 25, 2020.Of the 99 patients with 2019-nCoV pneumonia, 49 (49%) had a history of exposure to the Huanan seafood market.
The average age of the patients was 55·5 years (SD 13·1), including 67 men and 32 women. 2019-nCoV was detected in all patients by real-time RT-PCR. 50 (51%) patients had chronic diseases. Patients had clinical manifestations of fever (82 [83%] patients), cough (81 [82%] patients), shortness of breath (31 [31%] patients), muscle ache (11 [11%] patients), confusion (nine [9%] patients), headache (eight [8%] patients), sore throat (five [5%] patients), rhinorrhoea (four [4%] patients), chest pain (two [2%] patients), diarrhoea (two [2%] patients), and nausea and vomiting (one [1%] patient).
According to imaging examination, 74 (75%) patients showed bilateral pneumonia, 14 (14%) patients showed multiple mottling and ground-glass opacity, and one (1%) patient had pneumothorax. 17 (17%) patients developed acute respiratory distress syndrome and, among them, 11 (11%) patients worsened in a short period of time and died of multiple organ failure.The 2019-nCoV infection was of clustering onset, is more likely to affect older males with comorbidities, and can result in severe and even fatal respiratory diseases such as acute respiratory distress syndrome. In general, characteristics of patients who died were in line with the MuLBSTA score, an early warning model for predicting mortality in viral pneumonia. Further investigation is needed to explore the applicability of the MuLBSTA score in predicting the risk of mortality in 2019-nCoV infection.National Key R&D Program of China.

AFLP: a new technique for DNA fingerprinting.

A novel DNA fingerprinting technique called AFLP is described. The AFLP technique is based on the selective PCR amplification of restriction fragments from a total digest of genomic DNA. The technique involves three steps: (i) restriction of the DNA and ligation of oligonucleotide adapters, (ii) selective amplification of sets of restriction fragments, and (iii) gel analysis of the amplified fragments.
PCR amplification of restriction fragments is achieved by using the adapter and restriction site sequence as target sites for primer annealing. The selective amplification is achieved by the use of primers that extend into the restriction fragments, amplifying only those fragments in which the primer extensions match the nucleotides flanking the restriction sites. Using this method, sets of restriction fragments may be visualized by PCR without knowledge of nucleotide sequence. The method allows the specific co-amplification of high numbers of restriction fragments. The number of fragments that can be analyzed simultaneously, however, is dependent on the resolution of the detection system. Typically 50-100 restriction fragments are amplified and detected on denaturing polyacrylamide gels. The AFLP technique provides a novel and very powerful DNA fingerprinting technique for DNAs of any origin or complexity.

Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets.

Accurate normalization is an absolute prerequisite for correct measurement of gene expression. For quantitative real-time reverse transcription-PCR (RT-PCR), the most commonly used normalization strategy involves standardization to a single constitutively expressed control gene. However, in recent years, it has become clear that no single gene is constitutively expressed in all cell types and under all experimental conditions, implying that the expression stability of the intended control gene has to be verified before each experiment.
We outline a novel, innovative, and robust strategy to identify stably expressed genes among a set of candidate normalization genes. The strategy is rooted in a mathematical model of gene expression that enables estimation not only of the overall variation of the candidate normalization genes but also of the variation between sample subgroups of the sample set.
Notably, the strategy provides a direct measure for the estimated expression variation, enabling the user to evaluate the systematic error introduced when using the gene. In a side-by-side comparison with a previously published strategy, our model-based approach performed in a more robust manner and showed less sensitivity toward coregulation of the candidate normalization genes. We used the model-based strategy to identify genes suited to normalize quantitative RT-PCR data from colon cancer and bladder cancer. These genes are UBC, GAPD, and TPT1 for the colon and HSPCB, TEGT, and ATP5B for the bladder. The presented strategy can be applied to evaluate the suitability of any normalization gene candidate in any kind of experimental design and should allow more reliable normalization of RT-PCR data.

Hamster Uterus cDNA

AD-411 Zyagen 30 reactions
EUR 243

MiniPig Uterus cDNA

ND-411 Zyagen 30 reactions
EUR 358

Guinea Pig Uterus cDNA

GD-411 Zyagen 30 reactions
EUR 243

Cat Uterus Total RNA*

FR-411 Zyagen 0.05mg
EUR 195

Cat Uterus Genomic DNA

FG-411 Zyagen 0.1mg
EUR 210

Cat Uterus Total Protein

FT-411 Zyagen 1mg
EUR 176

cDNA - Human Tumor Tissue: Uterus

C1235274 Biochain 40 reactions
EUR 467.25

Rat Uterus, non-pregnant cDNA

RD-411 Zyagen 30 reactions
EUR 243

Mouse CD1 Uterus, non-pregnant cDNA

MD-411 Zyagen 30 reactions
EUR 243

Mouse BLC Uterus, non-pregnant cDNA

MD-411-BLC Zyagen 30 reactions
EUR 280

Mouse C57 Uterus, non-pregnant cDNA

MD-411-C57 Zyagen 30 reactions
EUR 280

cDNA - Human Adult Normal Tissue: Uterus

C1234274 Biochain 40 reactions
EUR 311.5

cDNA - Monkey (Rhesus) Normal Tissue: Uterus

C1534274 Biochain 40 reactions
EUR 531.3

cDNA - Monkey (Cynomolgus) Normal Tissue: Uterus

C1534274-Cy Biochain 40 reactions
EUR 531.3

cDNA - Human Adult Normal Tissue: Uterus: Cervix

C1234275 Biochain 40 reactions
EUR 311.5

cDNA - Human Adult Normal Tissue: Uterus: Corpus

C1234276-10 Biochain 10 reactions
EUR 173.95

cDNA - Human Adult Normal Tissue: Uterus: Fundus

C1234278-10 Biochain 10 reactions
EUR 173.95

cDNA - Monkey (Rhesus) Normal Tissue: Uterus: Cervix

C1534275 Biochain 40 reactions
EUR 531.3

cDNA - Monkey (Rhesus) Normal Tissue: Uterus: Corpus

C1534276 Biochain 40 reactions
EUR 531.3

cDNA - Monkey (Rhesus) Normal Tissue: Uterus: Fundus

C1534278 Biochain 40 reactions
EUR 531.3

Rat Uterus, non-pregnant cDNA-Random Primer

RD-411-RH Zyagen 30 reactions
EUR 243

cDNA - Monkey (Cynomolgus) Normal Tissue: Uterus: Cervix

C1534275-Cy Biochain 40 reactions
EUR 531.3

Rat WS Uterus, non-pregnant cDNA-Oligo-dT

RD-411-WS Zyagen 30 reactions
EUR 243

Mouse C57 Uterus, non-pregnant cDNA-Random Primer

MD-411-C57-RH Zyagen 30 reactions
EUR 280

Mouse CD1 Uterus, non-pregnant cDNA-Random Primer

MD-411-HR Zyagen 30 reactions
EUR 243

Tissue cDNA, First Strand, Human Tumor, Uterus, BioGenomics

MBS651979-40Tests MyBiosource 40Tests
EUR 850

Tissue cDNA, First Strand, Human Tumor, Uterus, BioGenomics

MBS651979-5x40Tests MyBiosource 5x40Tests
EUR 3600

Tissue cDNA, First Strand, Human Adult Normal, Uterus, BioGenomics

MBS651999-40Tests MyBiosource 40Tests
EUR 680

Tissue cDNA, First Strand, Human Adult Normal, Uterus, BioGenomics

MBS651999-5x40Tests MyBiosource 5x40Tests
EUR 2835

Tissue cDNA, First Strand, Human Adult Normal, Uterus, Cervix, BioGenomics

MBS651890-40Tests MyBiosource 40Tests
EUR 680

Tissue cDNA, First Strand, Human Adult Normal, Uterus, Cervix, BioGenomics

MBS651890-5x40Tests MyBiosource 5x40Tests
EUR 2835

Tissue cDNA, First Strand, Monkey (Rhesus) Adult Normal, Uterus, BioGenomics

MBS652015-40Tests MyBiosource 40Tests
EUR 850

Tissue cDNA, First Strand, Monkey (Rhesus) Adult Normal, Uterus, BioGenomics

MBS652015-5x40Tests MyBiosource 5x40Tests
EUR 3600

Tissue cDNA, First Strand, Human Adult Normal, Uterus, Corpus, BioGenomics

MBS652435-10Tests MyBiosource 10Tests
EUR 540

Tissue cDNA, First Strand, Human Adult Normal, Uterus, Corpus, BioGenomics

MBS652435-5x10Tests MyBiosource 5x10Tests
EUR 2215

Tissue cDNA, First Strand, Human Adult Normal, Uterus, Fundus, BioGenomics

MBS652490-10Tests MyBiosource 10Tests
EUR 540

Tissue cDNA, First Strand, Human Adult Normal, Uterus, Fundus, BioGenomics

MBS652490-5x10Tests MyBiosource 5x10Tests
EUR 2215

Tissue cDNA, First Strand, Monkey (Cynomolgus) Adult Normal, Uterus, BioGenomics

MBS652498-40Tests MyBiosource 40Tests
EUR 850

Tissue cDNA, First Strand, Monkey (Cynomolgus) Adult Normal, Uterus, BioGenomics

MBS652498-5x40Tests MyBiosource 5x40Tests
EUR 3600

Tissue cDNA, First Strand, Monkey (Rhesus) Adult Normal, Uterus, Fundus, BioGenomics

MBS652111-40Tests MyBiosource 40Tests
EUR 850

Tissue cDNA, First Strand, Monkey (Rhesus) Adult Normal, Uterus, Fundus, BioGenomics

MBS652111-5x40Tests MyBiosource 5x40Tests
EUR 3600

Tissue cDNA, First Strand, Monkey (Rhesus) Adult Normal, Uterus, Corpus, BioGenomics

MBS652277-40Tests MyBiosource 40Tests
EUR 850

Tissue cDNA, First Strand, Monkey (Rhesus) Adult Normal, Uterus, Corpus, BioGenomics

MBS652277-5x40Tests MyBiosource 5x40Tests
EUR 3600

Tissue cDNA, First Strand, Monkey (Rhesus) Adult Normal, Uterus, Cervix, BioGenomics

MBS652482-40Tests MyBiosource 40Tests
EUR 850

Tissue cDNA, First Strand, Monkey (Rhesus) Adult Normal, Uterus, Cervix, BioGenomics

MBS652482-5x40Tests MyBiosource 5x40Tests
EUR 3600

Tissue cDNA, First Strand, Monkey (Cynomolgus) Adult Normal, Uterus, Cervis, BioGenomics

MBS651910-40Tests MyBiosource 40Tests
EUR 850

Tissue cDNA, First Strand, Monkey (Cynomolgus) Adult Normal, Uterus, Cervis, BioGenomics

MBS651910-5x40Tests MyBiosource 5x40Tests
EUR 3600

Uterus Lysate

MBS151639-01mg MyBiosource 0.1mg
EUR 200

Uterus Lysate

MBS151639-5x01mg MyBiosource 5x0.1mg
EUR 880

Uterus, Rabbit

MBS639336-25Each MyBiosource 25Each
EUR 395

Uterus, Rabbit

MBS639336-5x25Each MyBiosource 5x25Each
EUR 1550

Uterus, Bovine

MBS639365-5Each MyBiosource 5Each
EUR 395

Uterus, Bovine

MBS639365-5x5Each MyBiosource 5x5Each
EUR 1550

Dog Uterus RNA*

DR-411 Zyagen 0.05mg
EUR 195

BOVINE, UTERUS, FRESH

8600861 Lampire Biologicals Laboratories 1EA
EUR 67.09

Uterus Tumor Lysate

MBS151717-01mg MyBiosource 0.1mg
EUR 260

Uterus Tumor Lysate

MBS151717-5x01mg MyBiosource 5x0.1mg
EUR 1140

Fetal Uterus Lysate

XBL-10431 ProSci 0.1 mg
EUR 632.4
Description: Fetal human uterus tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The fetal human uterus tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the uterus tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The uterus tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot.

PORCINE, UTERUS, FRESH

8604961 Lampire Biologicals Laboratories 1EA
EUR 65.63

BOVINE, UTERUS, FROZEN

8620861 Lampire Biologicals Laboratories 1EA
EUR 67.09

PORCINE, UTERUS, FROZEN

8624961 Lampire Biologicals Laboratories 1EA
EUR 65.63

Rat Uterus Fibroblasts

ABC-TC4237 AcceGen 1 vial Ask for price
Description: Rat uterus fibroblasts, 6-week Wistar rat

OORA00351-10U - UTERUS

OORA00351-10U Aviva Systems Biology 1Each
EUR 105

OORA00351-1EA - UTERUS

OORA00351-1EA Aviva Systems Biology 1Each
EUR 99

OORA00493-10U - UTERUS

OORA00493-10U Aviva Systems Biology 1Each
EUR 55

OORA00493-1EA - UTERUS

OORA00493-1EA Aviva Systems Biology 1Each
EUR 59

Uterus Membrane Lysate

XBL-11023 ProSci 0.1 mg
EUR 619.8
Description: Human uterus tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human uterus tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated uterus tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated uterus tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal.

Tissue, Total RNA, Human Adult Normal, Uterus, Corpus of Uterus, BioGenomics

MBS638682-001mg MyBiosource 0.01mg
EUR 485

Tissue, Total RNA, Human Adult Normal, Uterus, Corpus of Uterus, BioGenomics

MBS638682-5x001mg MyBiosource 5x0.01mg
EUR 1960

Tissue, Total RNA, Human Adult Normal, Uterus, Cervix of uterus, BioGenomics

MBS638538-005mg MyBiosource 0.05mg
EUR 495

Tissue, Total RNA, Human Adult Normal, Uterus, Cervix of uterus, BioGenomics

MBS638538-5x005mg MyBiosource 5x0.05mg
EUR 1995

Pig Uterus Total RNA

PR-411 Zyagen 0.1mg
EUR 235

Dog Uterus Genomic DNA

DG-411 Zyagen 0.1mg
EUR 210

Pig Uterus Genomic DNA

PG-411 Zyagen 0.1mg
EUR 177

Rat Uterus Genomic DNA

RG-411 Zyagen 0.1mg
EUR 177

Sheep Uterus Total RNA

SR-411 Zyagen 0.1mg
EUR 160

Bovine Uterus Total RNA

BR-411 Zyagen 0.1mg
EUR 160

Rabbit Uterus Total RNA

TR-411 Zyagen 0.1mg
EUR 160

Dog Uterus Total Protein

DT-411 Zyagen 1mg
EUR 176

Hamster Uterus Total RNA*

AR-411 Zyagen 0.05mg
EUR 160

Human Uterus Genomic DNA

HG-411 Zyagen 0.05mg
EUR 210

Mouse Uterus Genomic DNA

MG-411 Zyagen 0.1mg
EUR 177

MiniPig Uterus Total RNA

NR-411 Zyagen 0.1mg
EUR 231

Pig Uterus Total Protein

PT-411 Zyagen 1mg
EUR 153

Sheep Uterus Genomic DNA

SG-411 Zyagen 0.1mg
EUR 177

Bovine Uterus Genomic DNA

BG-411 Zyagen 0.1mg
EUR 177

Human Uterus Tumor lysate

HTL-1384 Alpha Diagnostics 1 mg
EUR 927.6

Equine Uterus Genomic DNA

GE-411 Zyagen 0.1mg
EUR 210

OORA00552-1U - Rat UTERUS

OORA00552-1U Aviva Systems Biology 1Each
EUR 60

Rabbit Uterus Genomic DNA

TG-411 Zyagen 0.1mg
EUR 177

Uterus tumor tissue array

UT802a TissueArray each
EUR 306
Description: Uterus tumor tissue array, including stromal and leiomyo sarcoma, endometrioid adenocarcinoma, chorionepithelioma, hydatidiform mole, clear cell carcinoma, carcinsarcoma, sarcomatoid carcinoma, with pathology grade, TNM/Stage (AJCC 8th edition), 80 cases/80 cores (cores size 1.5mm), replacing UT802

Uterus Tissue Slide (Normal)

11-401-10um ProSci 10 um
EUR 241.8

Uterus Tissue Slide (Normal)

11-401-4um ProSci 4 um
EUR 216.6

Uterus Tissue Slide (Benign)

11-402-10um ProSci 10 um
EUR 241.8

Uterus Tissue Slide (Benign)

11-402-4um ProSci 4 um
EUR 216.6

Chicken Uterus Genomic DNA

GC-411 Zyagen 0.1mg
EUR 177

Hamster Uterus Genomic DNA

GA-411 Zyagen 0.1mg
EUR 177

Human Uterus Tissue Lysate

IHUUTETL100UG Innovative research each
EUR 245
Description: Human Uterus Tissue Lysate

Uterus Tissue Slide (Benign)

MBS154229-10um MyBiosource 10um
EUR 210

Uterus Tissue Slide (Benign)

MBS154229-4um MyBiosource 4um
EUR 195

Uterus Tissue Slide (Benign)

MBS154229-5x10um MyBiosource 5x10um
EUR 920

Uterus Tissue Slide (Normal)

MBS154314-10um MyBiosource 10um
EUR 210

Uterus Tissue Slide (Normal)

MBS154314-4um MyBiosource 4um
EUR 195

Uterus Tissue Slide (Normal)

MBS154314-5x10um MyBiosource 5x10um
EUR 920

Human Uterus Tissue Lysate

MBS8420151-01mg MyBiosource 0.1mg
EUR 385

Human Uterus Tissue Lysate

MBS8420151-5x01mg MyBiosource 5x0.1mg
EUR 1540

OORA00552-1EA - Rat UTERUS

OORA00552-1EA Aviva Systems Biology 1Each
EUR 59

Pig Uterus Frozen Sections

PF-411 Zyagen 10 slides
EUR 261

Sheep Uterus Total Protein

ST-411 Zyagen 1mg
EUR 153

Total-RNA---Lupus:-Uterus

R1236274Lup-50 Biochain 50 ug
EUR 338.1

Bovine Uterus Total Protein

BT-411 Zyagen 1mg
EUR 153

Rabbit Uterus Total Protein

TT-411 Zyagen 1mg
EUR 153

57153-2 BV UTERUS 5 EA*

57153-2 Pel-Freez 5 EA
EUR 300

Uterus Tissue Slide (Abnormal)

11-419-10um ProSci 10 um
EUR 241.8

Uterus Tissue Slide (Abnormal)

11-419-4um ProSci 4 um
EUR 216.6

Hamster Uterus Total Protein

AT-411 Zyagen 1mg
EUR 153

Chicken Uterus Total Protein

CT-411 Zyagen 1mg
EUR 140

Uterus Tissue Slide (Abnormal)

MBS154337-10um MyBiosource 10um
EUR 210

Uterus Tissue Slide (Abnormal)

MBS154337-4um MyBiosource 4um
EUR 195

Uterus Tissue Slide (Abnormal)

MBS154337-5x10um MyBiosource 5x10um
EUR 920

MiniPig Uterus Total Protein

NT-411 Zyagen 1mg
EUR 176

OORA00523-1U - Rabbit UTERUS

OORA00523-1U Aviva Systems Biology 1Each
EUR 255

Pig Uterus Paraffin Sections

PP-411 Zyagen 10 slides
EUR 240

Sheep Uterus Frozen Sections

SF-411 Zyagen 10 slides
EUR 261

Uterus Membrane Tumor Lysate

XBL-11031 ProSci 0.1 mg
EUR 752.1
Description: Human uterus tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human uterus tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated uterus tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated uterus tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal.

Bovine Uterus Frozen Sections

BF-411 Zyagen 10 slides
EUR 261

Equine Uterus Frozen Sections

EF-411 Zyagen 10 slides
EUR 261

OORA00523-1EA - Rabbit UTERUS

OORA00523-1EA Aviva Systems Biology 1Each
EUR 239

Rabbit Uterus Frozen Sections

TF-411 Zyagen 10 slides
EUR 240

Uterus Tissue Slide (Adenomyoma)

11-432-10um ProSci 10 um
EUR 241.8

Uterus Tissue Slide (Adenomyoma)

11-432-4um ProSci 4 um
EUR 216.6

Hamster Uterus Frozen Sections

AF-411 Zyagen 10 slides
EUR 240

Human Uterus Paraffin Sections

HP-411 Zyagen 10 slides
EUR 319

Uterus Tissue Slide (Adenomyoma)

MBS154292-10um MyBiosource 10um
EUR 210

Uterus Tissue Slide (Adenomyoma)

MBS154292-4um MyBiosource 4um
EUR 195

Uterus Tissue Slide (Adenomyoma)

MBS154292-5x10um MyBiosource 5x10um
EUR 920

MiniPig Uterus Frozen Sections

NF-411 Zyagen 10 slides
EUR 307

OORA00470-10U - Hamster UTERUS

OORA00470-10U Aviva Systems Biology 1Each
EUR 75

OORA00470-1EA - Hamster UTERUS

OORA00470-1EA Aviva Systems Biology 1Each
EUR 69

Sheep Uterus Paraffin Sections

SP-411 Zyagen 10 slides
EUR 240

Bovine Uterus Paraffin Sections

BP-411 Zyagen 10 slides
EUR 240

Equine Uterus Paraffin Sections

EP-411 Zyagen 10 slides
EUR 240

OCPB00133-100UG - Uterus Lysate

OCPB00133-100UG Aviva Systems Biology 0.1mg
EUR 139

Uterus-Corpus Membrane Lysate

XBL-11037 ProSci 0.1 mg
EUR 619.8
Description: Human uterus-corpus tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human uterus-corpus tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated uterus-corpus tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated uterus-corpus tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal.

Uterus-Fundus Membrane Lysate

XBL-11040 ProSci 0.1 mg
EUR 619.8
Description: Human uterus-fundus tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human uterus-fundus tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated uterus-fundus tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated uterus-fundus tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal.

Rat Uterus-E12 Total RNA

RR-411-12 Zyagen 0.05mg
EUR 160

Rat Uterus-E13 Total RNA

RR-411-13 Zyagen 0.05mg
EUR 160

Rat Uterus-E14 Total RNA

RR-411-14 Zyagen 0.05mg
EUR 160

Rat Uterus-E15 Total RNA

RR-411-15 Zyagen 0.05mg
EUR 160

Rat Uterus-E16 Total RNA

RR-411-16 Zyagen 0.05mg
EUR 160

Rat Uterus-E17 Total RNA

RR-411-17 Zyagen 0.05mg
EUR 160

Rat Uterus-E18 Total RNA

RR-411-18 Zyagen 0.05mg
EUR 160

Rat Uterus-E19 Total RNA

RR-411-19 Zyagen 0.05mg
EUR 160

Rat Uterus-E20 Total RNA

RR-411-20 Zyagen 0.05mg
EUR 160

Hamster Uterus Paraffin Sections

AP-411 Zyagen 10 slides
EUR 228

MiniPig Uterus Paraffin Sections

NP-411 Zyagen 10 slides
EUR 307

Guinea Pig Uterus Total RNA

GR-411 Zyagen 0.1mg
EUR 160

Mini Pig Uterus Genomic DNA

GN-411 Zyagen 0.1mg
EUR 210

Mouse C57 Uterus Genomic DNA

MG-411-C57 Zyagen 0.05mg
EUR 210

Uterus Tissue Slide (Adenocarcinoma)

11-404-10um ProSci 10 um
EUR 241.8

Uterus Tissue Slide (Adenocarcinoma)

11-404-4um ProSci 4 um
EUR 216.6

Uterus Tissue Slide (Adenocarcinoma)

MBS154197-10um MyBiosource 10um
EUR 210

Uterus Tissue Slide (Adenocarcinoma)

MBS154197-4um MyBiosource 4um
EUR 195

Uterus Tissue Slide (Adenocarcinoma)

MBS154197-5x10um MyBiosource 5x10um
EUR 920

41253-2 RB UTERUS Y 25 EA*

41253-2 Pel-Freez 25 EA
EUR 263

Guinea Pig Uterus Genomic DNA

GG-411 Zyagen 0.1mg
EUR 177

Guinea Pig Uterus Total Protein

GT-411 Zyagen 0.5mg
EUR 153

Uterus cancer test tissue array

T093 TissueArray each
EUR 78
Description: Uterus cancer test tissue array, with normal endometrial tissue as control, including TNM, clinical stage and pathology grade, 2 serial sections, 6 cases/24 cores

Human Uterus Fetal Tissue Lysate

IHUUTEFSTL100UG Innovative research each
EUR 1133
Description: Human Uterus Fetal Tissue Lysate

Human Uterus Tumor Tissue Lysate

IHUUTETLT100UG Innovative research each
EUR 361
Description: Human Uterus Tumor Tissue Lysate

Human Uterus Fetal Tissue Lysate

MBS8420150-01mg MyBiosource 0.1mg
EUR 1465

Human Uterus Fetal Tissue Lysate

MBS8420150-5x01mg MyBiosource 5x0.1mg
EUR 6415

Human Uterus Tumor Tissue Lysate

MBS8420153-01mg MyBiosource 0.1mg
EUR 525

Human Uterus Tumor Tissue Lysate

MBS8420153-5x01mg MyBiosource 5x0.1mg
EUR 2180

Leiomyoma of uterus tissue array

SO806 TissueArray each
EUR 270
Description: Leiomyoma of uterus tissue array, 80 cases/80 cores

Monkey Rhesus Uterus Genomic DNA

UG-411 Zyagen 0.1mg
EUR 210

Guinea Pig Uterus Frozen Sections

GF-411 Zyagen 10 slides
EUR 240

OORA00440-10U - GUINEA PIG UTERUS

OORA00440-10U Aviva Systems Biology 1Each
EUR 80

OORA00440-1EA - GUINEA PIG UTERUS

OORA00440-1EA Aviva Systems Biology 1Each
EUR 79

Guinea Pig Uterus Paraffin Sections

GP-411 Zyagen 10 slides
EUR 228

Monkey Cynomolgus Uterus Genomic DNA

KG-411 Zyagen 0.1mg
EUR 210

Human Uterus Lysate Membrane Fraction

IHUUTETLM100UG Innovative research each
EUR 870
Description: Human Uterus Lysate Membrane Fraction

OCPB00088-100UG - Uterus Tumor Lysate

OCPB00088-100UG Aviva Systems Biology 0.1mg
EUR 199

OCPB00611-100UG - Fetal Uterus Lysate

OCPB00611-100UG Aviva Systems Biology 0.1mg
EUR 579

Human Uterus Lysate Membrane Fraction

MBS8420152-01mg MyBiosource 0.1mg
EUR 1145

Human Uterus Lysate Membrane Fraction

MBS8420152-5x01mg MyBiosource 5x0.1mg
EUR 4960

Rat Uterus, non-pregnant Total RNA

RR-411 Zyagen 0.1mg
EUR 160

OCPB00744-100UG - Uterus Membrane Lysate

OCPB00744-100UG Aviva Systems Biology 0.1mg
EUR 559

Uterus Tissue Slide (Spindle Cell Tumor)

11-418-10um ProSci 10 um
EUR 241.8

Uterus Tissue Slide (Spindle Cell Tumor)

11-418-4um ProSci 4 um
EUR 216.6

Uterus Tissue Slide (Spindle Cell Tumor)

MBS154209-10um MyBiosource 10um
EUR 210

Uterus Tissue Slide (Spindle Cell Tumor)

MBS154209-4um MyBiosource 4um
EUR 195

Uterus Tissue Slide (Spindle Cell Tumor)

MBS154209-5x10um MyBiosource 5x10um
EUR 920

Tissue, Total Protein, Human Tumor, Uterus

MBS657307-1mg MyBiosource 1mg
EUR 680

Tissue, Total Protein, Human Tumor, Uterus

MBS657307-5x1mg MyBiosource 5x1mg
EUR 2835
×

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • NCBI References of Lab reagents
  • References of Lab monoclonals
  • NCBI References of Lab recombinants
  • Manufacturers of Lab Assays
  • Compare antibodies lab reagents for research

Recent Comments

    Categories

    • antibody
    • cDNA
    • elisa kits
    • Isotype
    • Lenti
    • pcr
    • peptide
    • rna
    • Uncategorized
    • vector
    June 2025
    M T W T F S S
     1
    2345678
    9101112131415
    16171819202122
    23242526272829
    30  
    « Feb    

    Categories

    • antibody
    • cDNA
    • elisa kits
    • Isotype
    • Lenti
    • pcr
    • peptide
    • rna
    • Uncategorized
    • vector

    Recent Posts

    • NCBI References of Lab reagents
    • References of Lab monoclonals
    • NCBI References of Lab recombinants
    • Manufacturers of Lab Assays
    • Compare antibodies lab reagents for research
    © 2025 International Union of Quaternary Research (INQUA), INQUA – Commission on Stratigraphy and Chronology (SACCOM) | Powered by Superbs Personal Blog theme